Politico October 4, 2024
Carmen Paun, Erin Schumaker, Daniel Payne and Ruth Reader

FORWARD THINKING

America needs “a bold reimagining and reconfiguration” of biological and medical research to ensure that it responds to the health challenges most relevant to Americans, two top experts argue.

The National Institutes of Health, the largest federal funder of such research, doesn’t offer that, Drs. Victor Dzau, the president of the National Academy of Medicine, and E. Albert Reece, director of the Center for Advanced Research Training and Innovation at the University of Maryland School of Medicine, wrote this week in The New England Journal of Medicine.

The NIH’s 27 institutes and centers lack purposeful and structured coordination and focus, they argue.

The U.S. should set up a national advisory body that would oversee a national strategic vision...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Pharma / Biotech
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article